QQ客服 官方微博 反馈留言

	A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes
	Li, Huafang; Shen, Yifeng; Wang, Gang; Shi, Jianguo; Ma, Cui; Xie, Shiping; Zhang, Honggeng; Wang, Xiaoping; Li, Keqing; Xu, Xiufeng
刊名	PSYCHIATRY RESEARCH
	2018
卷号	259
关键词	Quetiapine XR Chlorpromazine Efficacy Safety Schizophrenia Acute episodes
ISSN号	0165-1781
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3416892
专题	昆明医科大学
推荐引用方式 GB/T 7714	Li, Huafang,Shen, Yifeng,Wang, Gang,et al. A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes[J]. PSYCHIATRY RESEARCH,2018,259.
APA	Li, Huafang.,Shen, Yifeng.,Wang, Gang.,Shi, Jianguo.,Ma, Cui.,...&Gu, Niufan.(2018).A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes.PSYCHIATRY RESEARCH,259.
MLA	Li, Huafang,et al."A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes".PSYCHIATRY RESEARCH 259(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。